Amanote Research
Register
Sign In
A Cost Utility Analysis of CYP2D6 Pharmacogenetic Guided Dosing Versus Standard Dosing of Risperidone for Treatment of Schizophrenia
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.03.1271
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2014
Authors
T. Yep
B. Devine
Publisher
Elsevier BV